Adropin Treatment Shows Promise to Limit Post-stroke Brain Damage in Mouse Study
Center member Eduardo Canderlario-Jalil and his team have identified a new potential way to minimize brain damage caused by ischemic stroke: treatment using a synthetic form of adropin, a molecule naturally produced in mammals. Findings from the preclinical mouse-model study, published today in the journal Stroke, offer hope of adding…